Navigation Links
21st European Biomass Conference and Exhibition
Date:5/21/2013

The largest gathering of biomass experts

Where? Copenhagen, Denmark: Bella Center Congress Centre

When? 03-07 June 2013

Why? An annual meeting focusing on scientific research, resource assessment, market and policy developments, manufacturing and installation, drawing on leading experiences from all over the world and benefiting from its 2013 edition from a record of more than 900 abstracts received from more than 60 countries, more than 240 plenary and oral presentations, more than 460 visual presentation, 55 exhibitors already confirmed and 2,000 attendees including representatives of over 1000 organisations expected.

Who? A conglomerate of researchers, engineers, technologists, stakeholders from standard and scientific organizations and renewable energy groups, global investors, financing institutions, European and international policy and decision makers, international delegations.

21st European Biomass Conference and Exhibition

The European Biomass Conference and Exhibition represents one of the key events in Europe and worldwide for companies and professionals operating at the top end of the biomass and bioenergy sector.

This year the event will be hosted in Copenhagen, Denmark, a clearly ideal location for the 21 st edition of this world-class event. Denmark is, in fact, globally acknowledged as a hub for cleantech companies and as an example of sustainable development in renewables; it features leading companies and research organizations in large-scale applications of biomass such as co-firing, as well as in small-scale applications such as co-generation, biomass for heating, biogas and algae, and it also houses important world players in the development of 2nd generation biofuels.

The City of Copenhagen has set the goal to be CO2-neutral in 2025 - as the first capital in the world. In light of this, the Conference, by bringing the la
'/>"/>

Contact: Chiara Benetti
pressoffice@etaflorence.it
39-055-500-2280
Eta Florence Renewable Energies
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
2. An invasive Asian fly is taking over European fruit
3. Building the European Unions Natura 2000 -- the largest ever network of protected areas
4. European grasslands challenge rainforests as the most species-rich spaces on Earth
5. European mountain plant population shows delayed response to climate change
6. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
7. Citizen science helps unlock European genetic heritage
8. PETA files complaint with European ombudsman over animal testing for REACH
9. First Indian-European research networking projects in the social sciences launched
10. Ukraine to Introduce European Standard of Biometric ID
11. BiOptix to highlight new 404pi instrument at European symposia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends and ... recognition is forecast to reach US$ 2,671.8 Mn by ... surveillance systems by civil and government agencies. This is ... terrorist activities across the globe that would elevate the ...
(Date:8/4/2015)... , Aug. 04, 2015 ... http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition of ... (Hardware, Software, and Service), Sub-Segment (Computer Forensics, ... Forensics), Tool Types, Service, Vertical and Region ... to their offering. By Component ...
(Date:8/3/2015)... JOSE, Calif. , Aug. 3, 2015 ... of human interface solutions, today announced that members of ... community at the Pacific Crest Global Technology Leadership Forum ... Time. The conference will be held at the Sonnenalp ... The presentation may include forward-looking information. An ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... a more serious threat to marine life than previously ... today (19 July) in the British Ecological Society,s ... thousands of turtles from across the Pacific are being ... on fisheries in Peru, the study suggests that thousands ...
... that, when mutated, change healthy cells into cancerous tumor cells. ... of Southern California (USC) have proven that those genes also ... to a safer and more practical approach to treating diseases ... "The reality may be more complicated than people think," said ...
... delivers new insight about rapid toxin evolution in venomous snakes: ... race with opossums, a group of snake-eating American marsupials. Although ... this fact has not been factored into previous explanations for ... usually seen as a feeding, or trophic, adaptation. But new ...
Cached Biology News:Study shows small-scale fisheries' impact on marine life 2USC research: Cancer cells and stem cells share same origin 2Rapid venom evolution in pit vipers may be defensive 2Rapid venom evolution in pit vipers may be defensive 3
(Date:9/2/2015)... 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... manufacturing equipment, to creating professional commercial video content, to analysis of athletic performance. ... fascinating events that go by too quickly to process with the naked eye. ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... Researchers at the ... role in the circadian clock in plants. The finding, to appear in the journal The Plant ... , ... Researchers at the RIKEN Plant Science Center have clarified the function of three proteins ...
... Md. , March 17  OriGene Technologies, ... completion of a $16 million Series B ... Enterprise, and Zero2IPO. OriGene,s previous investors Morningside ... participated in this round.  The proceeds from the funding ...
... ZMH ; SIX: ZMH) announced today it will be participating in the Barclays Capital 2010 Global Healthcare Conference in Miami, Fla. , on March 23, 2010 , at 8:30 ... ... ... ...
Cached Biology Technology:RIKEN Plant Science Center Research Reveals the Proteins That Help Plants Keep Time 2OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 2OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 3Zimmer Holdings to Present at Barclays Capital 2010 Global Healthcare Conference 2
... ZMD.437. Immunogen: Synthetic peptide derived from ... and rat ZO-1. Specificity: Specific for ... protein. Reactivity: Human Dog Rat Mouse ... cells frozen mouse liver heart blood vessel ...
Rabbit polyclonal to Syntrophin alpha 1 ( Abpromise for all tested applications). entrezGeneID: 6640 SwissProtID: Q13424...
Mitotic Kinesin-Like Protein 1 (MKLP-1, KNSL5)...
Gastric Carcinoma Marker [BY-1 (3H11)]...
Biology Products: